| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/01/2009 | US20090005399 Substituted Imidazo[2,1-b]thiazole Compounds and Uses Thereof |
| 01/01/2009 | US20090005398 Methods For The Treatment of Central Nervous System Tumors |
| 01/01/2009 | US20090005397 Substituted Oxindol Derivatives and Medicaments Containing the Same |
| 01/01/2009 | US20090005396 Use of Pyrazolyl-Pyrimidine Derivatives in the Treatment of Pain |
| 01/01/2009 | US20090005395 Sildenafil n-oxide as prodrug |
| 01/01/2009 | US20090005394 Endothelin receptor antagonists |
| 01/01/2009 | US20090005393 Pyridine and Pyrimidine Derivatives as Inhibitors of Histone Deacetylase |
| 01/01/2009 | US20090005392 Crystal of 6-[4-(4-pyridylamino) phenyl]-4,5-dihydro-3(2h-pyridazinone hydrochloride trihydrate |
| 01/01/2009 | US20090005391 Tricyclo Substituted Amides |
| 01/01/2009 | US20090005390 Novel quinuclidine derivatives and their use |
| 01/01/2009 | US20090005389 2,5 Diaza-Bicyclo [2.2.1] Heptane Derivatives as Calcium Channel Blockers |
| 01/01/2009 | US20090005388 3-Heteroaryl-3,9-Diazabicyclo[3.3.1]Nonane Derivatives as Nicotinic Acetylcholine Receptor Agonists |
| 01/01/2009 | US20090005387 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 01/01/2009 | US20090005386 Methods for Modulating Ion Channels |
| 01/01/2009 | US20090005385 Treatment or Prevention of Cancer or Cardiovascular Disease with Methenyltetrahydrofolate Synthetases |
| 01/01/2009 | US20090005384 Method for Producing Adsorptive Porous Body |
| 01/01/2009 | US20090005383 Thyroid hormone analogs |
| 01/01/2009 | US20090005382 Methods of using and compositions comprising tryptophan hydroxylase inhibitors |
| 01/01/2009 | US20090005381 Methods of treating serotonin-mediated diseases and disorders |
| 01/01/2009 | US20090005380 Cyclohexyl derivatives |
| 01/01/2009 | US20090005379 Azaindole-2-Carboxamide Derivatives |
| 01/01/2009 | US20090005378 Pyrrolo-pyridine kinase modulators |
| 01/01/2009 | US20090005377 Pyrazolopyridine Derivates |
| 01/01/2009 | US20090005376 1-Alkoxy 1H-Imidazo Ring Systems and Methods |
| 01/01/2009 | US20090005375 Acetyl coenzyme a carboxylase inhibitors |
| 01/01/2009 | US20090005374 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 01/01/2009 | US20090005373 Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/01/2009 | US20090005372 Cyclopropanecarboxylic acid {4-[3-(4-methoxy-phenyl)-[1,2,4]triazolo[3,4-a]phthalazin-6-ylamino]-phenyl}-amide; phosphodiesterase inhibitors; neoangiogenesis or inflammatory disease |
| 01/01/2009 | US20090005371 Substituted Fused [1,2]Imidazo[4,5-C] Ring Compounds and Methods |
| 01/01/2009 | US20090005370 Isoxazole-imidazole derivatives |
| 01/01/2009 | US20090005369 Oxazolidinone Compounds and Compositions and Methods Related Thereto |
| 01/01/2009 | US20090005368 such as 6-({trans-4-[(1R)-1-hydroxy-2-(3-methoxy-quinolin-5-yl)-ethyl]-cyclohexylamino}-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one for treating infections from Streptococcus pneumoniae, Haemophilus influenzae, Moraxella, Staphylococcus, Enterococcus |
| 01/01/2009 | US20090005367 Composition and method for treating alcoholism and other substance addictions |
| 01/01/2009 | US20090005366 Deuterium-enriched olanzapine |
| 01/01/2009 | US20090005365 Therapeutic pyrazolonaphthyridine derivatives |
| 01/01/2009 | US20090005364 Azole Derivatives With Antimuscarinic Activity |
| 01/01/2009 | US20090005363 Organic Compounds |
| 01/01/2009 | US20090005362 Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same |
| 01/01/2009 | US20090005361 Combination of Organic Compounds |
| 01/01/2009 | US20090005360 Modified release preparations containing oxcarbazepine and derivatives thereof |
| 01/01/2009 | US20090005359 Heterocyclic Compounds Useful as RAF Kinase Inhibitors |
| 01/01/2009 | US20090005358 Compositions and methods for treating medical conditions |
| 01/01/2009 | US20090005357 Pharmacological Treatment for Sleep Apnea |
| 01/01/2009 | US20090005356 Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators |
| 01/01/2009 | US20090005355 Piperidine Compound and Process for Preparing the Same |
| 01/01/2009 | US20090005354 New Amino Derivatives and Their Use as Pharmaceuticals |
| 01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
| 01/01/2009 | US20090005352 2,6-(diisopropyl)phenyl 1-[((2S)-2-amino-3-methylbutyryl)aminomethyl]-1-cyclohexane acetate; migraine, nausea, vomiting, anxiety, seizures, convulsions, trauma of the central nervous system, and neurodegenerative conditions of Friedrich's, Parkinson's, Alzheimer's, Huntington's diseases |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005350 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/01/2009 | US20090005349 Therapeutic uses of glutathione mimics |
| 01/01/2009 | US20090005348 Compounds Having Cytokine Modulating Properties |
| 01/01/2009 | US20090005347 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 01/01/2009 | US20090005346 Azacytosine Derivatives Useful as Antiviral Agents |
| 01/01/2009 | US20090005345 Detoxification of Shellfish |
| 01/01/2009 | US20090005344 Blocking inflammatory cytokines; tumor necrosis factor; phosphodieaterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders; chronic obstructive pulmonary disorders |
| 01/01/2009 | US20090005343 B-cyclodextrin derivatives and their use against anthrax lethal toxin |
| 01/01/2009 | US20090005342 Composition Having Blood Pressure Reducing and/or Elevation Suppressing Effect and Food and Drink Containing the Same |
| 01/01/2009 | US20090005341 Process for the preparation of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 01/01/2009 | US20090005340 Bioactive Agents Produced By Submerged Cultivation of a Basidiomycete Cell |
| 01/01/2009 | US20090005339 Methods of Treating Ear Infections |
| 01/01/2009 | US20090005338 Carbonyl-substituted titanocenes |
| 01/01/2009 | US20090005337 Phosphodiesterases (PDE); used for screening for Cushing's syndrome or bilateral adrenocortical hyperplasia (BAH) |
| 01/01/2009 | US20090005336 Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions |
| 01/01/2009 | US20090005335 Compounds for the modulation of beta-catenin expression |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005333 Reducing culling in herd animals growth hormone releasing hormone (ghrh) |
| 01/01/2009 | US20090005332 Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides |
| 01/01/2009 | US20090005331 AChE antisense oligonucleotide as an anti-inflammatory agent |
| 01/01/2009 | US20090005330 Methods and Compositions to Inhibit P2x7 Receptor Expression |
| 01/01/2009 | US20090005328 Methods of modulating tubulin deacetylast activity |
| 01/01/2009 | US20090005327 Essential n-3 fatty acids in cardiac in sufficiency and heart failure therapy |
| 01/01/2009 | US20090005326 Single dose roxithromycin |
| 01/01/2009 | US20090005325 Ketolide Derivatives as Antibacterial Agents |
| 01/01/2009 | US20090005324 Biologically active extract from dendrobium plant, use thereof and process for preparing the same |
| 01/01/2009 | US20090005323 Cathepsin K Inhibitors and Obesity |
| 01/01/2009 | US20090005321 Phenylazetidinone Derivatives |
| 01/01/2009 | US20090005320 Compositions comprising amino acid bicarbonate and methods of use thereof |
| 01/01/2009 | US20090005314 Compositions and Methods for Modulating Pgc-1Alpha to Treat Neurological Diseases and Disorders |
| 01/01/2009 | US20090005309 Substituted piperidines |
| 01/01/2009 | US20090005305 Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005302 Method, apparatus, and compound for effecting localized, non-systemic, immunogenic treatment of cancer |
| 01/01/2009 | US20090005301 207 Human Secreted Proteins |
| 01/01/2009 | US20090005295 Syndecans and angiogenesis |
| 01/01/2009 | US20090005293 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004690 Composition and methods for making 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine |
| 01/01/2009 | US20090004669 Methods of diagnosing pre-eclampsia or eclampsia |
| 01/01/2009 | US20090004312 Use of Neurotoxin Therapy for Treatment of Urologic and Related Disorders |
| 01/01/2009 | US20090004309 Anti-Gastritis and Anti-Ulcer Agent Containing Momordicae Semen Extract and Momordica Saponin I Isolated From the Same |
| 01/01/2009 | US20090004308 Use of organic acids and essential oils in animal feeding |
| 01/01/2009 | US20090004307 Aloe Vera Extract, Method of Producing Aloe Vera Extract, and Hyperglycemia Improving Agent |
| 01/01/2009 | US20090004304 Composition comprising bioactive substance |
| 01/01/2009 | US20090004299 Methods for Inhibiting a Decline in Learning and/or Memory in Animals |
| 01/01/2009 | US20090004298 Use of S-Nitrosothiol Signaling to Treat Disordered Control of Breathing |
| 01/01/2009 | US20090004293 breast cancer, melanoma, colon cancer, leukemia and lymphoma, and other cancer cells |
| 01/01/2009 | US20090004292 Methods and compositions for deterring abuse of opioid containing dosage forms |
| 01/01/2009 | US20090004290 Red yeast rice compound for cancer chemoprevention |
| 01/01/2009 | US20090004286 Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same |